Elevance Health Triumphs in Q3 Earnings: A Robust Farewell to CFO John Gallina
2024 is the year of Carelon execution
Elevance reported earnings Wednesday morning and is battling against the headwinds presented by challenges in Medicaid Redetermination. Despite this, Elevance soared past expectations, delivering a strong performance that affirmed their resilience.
A highlight of this quarter’s achievements is the impressive 20% growth in Earnings Per Share (EPS), a form…
Keep reading with a 7-day free trial
Subscribe to The Healthcare Economy to keep reading this post and get 7 days of free access to the full post archives.